The University of Texas Health Science Center at Houston
Houston, Texas, 77479, United States
Location contact
Jude des Bordes, MBChB, DrPH
CONTACT
Nahid Rianon, MBBS,DrPH
CONTACT
NCT Number: NCT06671847
The purpose of this study is to determine the feasibility of implementing a 24-week at-home chair-based resistance band training intervention, to determine effectiveness of a the a 24-week at-home chair-based resistance band training intervention in improving body composition and to determine the effectiveness of a 24-week at-home chair-based resistance band training intervention in improving physical performance in adults 50 years and older, receiving care at the UT Physicians Center for Healthy Aging.
Trial opening soon.
Get Notified50 year and older
All sexes
Interventional
Not applicable
Houston, Texas, 77479, United States
Jude des Bordes, MBChB, DrPH
CONTACT
Nahid Rianon, MBBS,DrPH
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The training will be performed using THERABand resistance exercise bands.Participants will be instructed to perform the exercises twice per week at home, for the 24 weeks duration. Each exercise session will entail 1 set of 15 repetitions of 9 different exercises
Time frame: end of study (24 weeks from baseline)
Time frame: baseline,6-months
This will be assessed using the handheld bioelectrical impedance analysis (BIA) device (Omron HBF-510)
Time frame: baseline, 1 year from baseline
This will be assessed by the Dual energy x-ray absorptiometry (DXA)
Time frame: baseline
This will be assessed using a validated handgrip dynamometer
Time frame: 1-month
This will be assessed using a validated handgrip dynamometer
Time frame: 3-months
This will be assessed using a validated handgrip dynamometer
Time frame: 6-months
This will be assessed using a validated handgrip dynamometer
Time frame: Baseline
This is determined by the patient standing on the Zibrio Stability Pro Scale unassisted for one minute and will be measured on a scale of 1 to 9 with lower scores indicating higher risk of fall
Time frame: 1-month
This is determined by the patient standing on the Zibrio Stability Pro Scale unassisted for one minute and will be measured on a scale of 1 to 9 with lower scores indicating higher risk of fall
Time frame: 3-months
This is determined by the patient standing on the Zibrio Stability Pro Scale unassisted for one minute and will be measured on a scale of 1 to 9 with lower scores indicating higher risk of fall
Time frame: 6-months
This is determined by the patient standing on the Zibrio Stability Pro Scale unassisted for one minute and will be measured on a scale of 1 to 9 with lower scores indicating higher risk of fall
Time frame: Baseline
Gait speed will be assessed over a 6-meter distance measured within a private clinic space. The participant will be instructed to walk at their normal walking pace (as if they were walking throughout the house) and the distance/time will be converted to meters/second.Faster walking speed is related to reduced fall-risk, improved physical function, and greater survival .
Time frame: 1-month
Gait speed will be assessed over a 6-meter distance measured within a private clinic space. The participant will be instructed to walk at their normal walking pace (as if they were walking throughout the house) and the distance/time will be converted to meters/second.Faster walking speed is related to reduced fall-risk, improved physical function, and greater survival .
Time frame: 3-months
Gait speed will be assessed over a 6-meter distance measured within a private clinic space. The participant will be instructed to walk at their normal walking pace (as if they were walking throughout the house) and the distance/time will be converted to meters/second.Faster walking speed is related to reduced fall-risk, improved physical function, and greater survival .
Time frame: 6-months
Gait speed will be assessed over a 6-meter distance measured within a private clinic space. The participant will be instructed to walk at their normal walking pace (as if they were walking throughout the house) and the distance/time will be converted to meters/second.Faster walking speed is related to reduced fall-risk, improved physical function, and greater survival .
Time frame: Baseline
P1NP is a metabolic marker of bone formation, indicates status of bone loss and a stable or decreased level will be indicating improved metabolism
Time frame: 6 months
P1NP is a metabolic marker of bone formation, indicates status of bone loss and a stable or decreased level will be indicating improved metabolism
Time frame: Baseline
This consists of 5 items (unintentional weight loss, weakness [low grip strength], slowness low, self-reported exhaustion and low physical activity). Patients who meet 1or 2 of the criteria are described as pre-frail and 3 or more as frail.
Time frame: 1-month
This consists of 5 items (unintentional weight loss, weakness [low grip strength], slowness low, self-reported exhaustion and low physical activity). Patients who meet 1or 2 of the criteria are described as pre-frail and 3 or more as frail.
Time frame: 3-months
This consists of 5 items (unintentional weight loss, weakness [low grip strength], slowness low, self-reported exhaustion and low physical activity). Patients who meet 1or 2 of the criteria are described as pre-frail and 3 or more as frail.
Time frame: 6-months
This consists of 5 items (unintentional weight loss, weakness [low grip strength], slowness low, self-reported exhaustion and low physical activity). Patients who meet 1or 2 of the criteria are described as pre-frail and 3 or more as frail.
Contact information is provided by the study sponsor or research team.
Jude des Bordes, MBChB, DrPH
CONTACT
Nahid Rianon, MBBS,DrPH
CONTACT
The University of Texas Health Science Center, Houston
Other
Feasibility of 24-Weeks of At-Home Chair-Based Resistance Band Training to Improve Balance, Strength, and Bone Density in Older Adults (ChaREx Study)
Acronym: ChaREx
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07710456
Atrophy, Body Weight
View Trial DetailsNCT07433309
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT07030738
Aging, Atrophy
Tel Aviv, Israel
View Trial DetailsNCT06933823
Sarcopenic Obesity
Hong Kong
View Trial Details